Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: mike wood who wrote (10771)	7/8/1998 11:46:00 AM
From: VLAD	Read Replies (1) \| Respond to of 23519

Gentlemen (and E'Lane), Quit trying to expect a straight line run up to the 20's cause it aint gonna happen. Those buying in at the 5 13/16 to 8 range are anxious to pocket some quick profits. The real picture should be clear in one day--if the news is real good then we very well may see a rapid move to the upside. If the news is so so then you can expect some sort of basing pattern with script data and any unit sales info provided on international sales to determine future price direction. One ace in the hole is Viagra--if it gets pulled then you can expect a run to 20+ on such news but don't hold ye breath. Sadly, a continued uptrend in the Viagra body count should also help as more and more will not believe the bs spewed by PFE and the FDA. A nice BIG FAT class action lawsuit directed at Pfizer will also help and it will happen in the not so far future. Despite Q2 earnings, an alliance with a strong domestic partner can also give us a nice hard run to the upside. The more Vivus concentrates on R&D and MUSE production the better for the stock price. Vivus needs to leave the marketing and sales part to someone who knows what they are doing.